Literature DB >> 12928872

Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs.

G von Samson-Himmelstjerna1, C Epe, A Schimmel, J Heine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928872     DOI: 10.1007/s00436-003-0907-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


× No keyword cloud information.
  4 in total

1.  Survey of intestinal parasites in stray dogs in the Madrid area and comparison of the efficacy of three anthelmintics in naturally infected dogs.

Authors:  Guadalupe Miró; Marta Mateo; Ana Montoya; Enrique Vela; Rosa Calonge
Journal:  Parasitol Res       Date:  2006-08-17       Impact factor: 2.289

2.  Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi® for Dogs) for the prevention of heartworm disease and infection all month long.

Authors:  Dwight D Bowman; Cameon M Ohmes; Joseph A Hostetler; Daniel J Keil; Terry L Settje; Samuel D Charles
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

3.  Development of advantus(imidacloprid) soft chewable tablets for the treatment of Ctenocephalides felis infestations on dogs.

Authors:  Tariq Qureshi; William R Everett; Kathleen G Palma
Journal:  Parasit Vectors       Date:  2015-08-04       Impact factor: 3.876

4.  Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs.

Authors:  Dwight D Bowman; Alyssa R Grazette; Chris Basel; Yingying Wang; Joseph A Hostetler
Journal:  Parasit Vectors       Date:  2016-01-08       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.